APA (7th ed.) Citation

Nakatani, E., Ohno, H., Nagahama, T., Tonoike, T., Yui, H., Satoh, T., . . . Sugawara, A. (2025). Comparative effectiveness of biguanides versus SGLT2 inhibitors on cardiovascular and cerebrovascular events, diabetic nephropathy, retinopathy, neuropathy, and treatment expenditures in patients with type 2 diabetes. PLoS ONE, 20(11), 1. https://doi.org/10.1371/journal.pone.0336038

Chicago Style (17th ed.) Citation

Nakatani, Eiji, et al. "Comparative Effectiveness of Biguanides Versus SGLT2 Inhibitors on Cardiovascular and Cerebrovascular Events, Diabetic Nephropathy, Retinopathy, Neuropathy, and Treatment Expenditures in Patients with Type 2 Diabetes." PLoS ONE 20, no. 11 (2025): 1. https://doi.org/10.1371/journal.pone.0336038.

MLA (9th ed.) Citation

Nakatani, Eiji, et al. "Comparative Effectiveness of Biguanides Versus SGLT2 Inhibitors on Cardiovascular and Cerebrovascular Events, Diabetic Nephropathy, Retinopathy, Neuropathy, and Treatment Expenditures in Patients with Type 2 Diabetes." PLoS ONE, vol. 20, no. 11, 2025, p. 1, https://doi.org/10.1371/journal.pone.0336038.